Deadline Nears For Comments On WHO’s Proposed Requirements For MAbs Targeting RSV

 
• By Vibha Sharma

The World Health Organization has developed a draft addendum to its 2023 guideline on the evaluation of mAbs intended for the prevention or treatment of infectious diseases, focusing on supplementary aspects specific to respiratory syncytial virus disease.

Patient child do inhalation with mask on his face to heal RSV (Respiratory Syncytial Virus)
RSV infection is a major cause of respiratory disease globally • Source: Shutterstock

More from International

More from Geography